Question 3: How should the sequence(s) be represented in the sequence listing? Peptides 1-6 must be represented with separate sequence identifiers: RISL (SEQ ID NO: 26) LLKK (SEQ ID NO: 27) IPACTA (SEQ ID NO: 28) FRAGGK (SEQ ID NO: 29) HQYFA (SEQ ID NO: 30) ATFGKKKA (SEQ ID NO: 31) The cross linkage is preferably noted using the feature key and the mandatory qualifier with the value “SITE” “NOTE” e.g., sequence is one part of a branched peptideamino acid sequence”. According to ST.26 paragraph 29, SEQ “This ID NOs 27, 29, and 31, must include an annotation for each lysine to indicate that it is a modified amino acid, using the feature key together with the qualifier describing that the side chain of the lysine is linked via an amide “SITE” “NOTE” linkage to another sequence. Preferably, each of SEQ ID Nos 26, 28 and 30 should include an annotation to indicate that the C-terminal amino acid is linked to another sequence, using the feature key together with the qualifier “SITE” “NOTE”. Paragraphs 8, 26, 29, 30, and 31 Relevant ST.26 paragraphs: 7(b),
Question 3: How should the sequence(s) be represented in the sequence listing? Peptides 1-6 must be represented with separate sequence identifiers: RISL (SEQ ID NO: 26) LLKK (SEQ ID NO: 27) IPACTA (SEQ ID NO: 28) FRAGGK (SEQ ID NO: 29) HQYFA (SEQ ID NO: 30) ATFGKKKA (SEQ ID NO: 31) The cross linkage is preferably noted using the feature key “SITE” and the mandatory qualifier “NOTE” with the value e.g., “This sequence is one part of a branched peptideamino acid sequence”. According to ST.26 paragraph 29, SEQ ID NOs 27, 29, and 31, must include an annotation for each lysine to indicate that it is a modified amino acid, using the feature key “SITE” together with the qualifier “NOTE” describing that the side chain of the lysine is linked via an amide linkage to another sequence. Preferably, each of SEQ ID Nos 26, 28 and 30 should include an annotation to indicate that the C-terminal amino acid is linked to another sequence, using the feature key “SITE” together with the qualifier “NOTE”. Relevant ST.26 paragraphs: Paragraphs 7(b), 8, 26, 29, 30, and 31
cws_6_16-annex6.docx